Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 3
1951 2
1952 4
1953 3
1954 2
1955 2
1956 1
1957 3
1958 2
1959 2
1960 3
1961 8
1962 9
1963 12
1964 19
1965 17
1966 26
1967 17
1968 18
1969 20
1970 26
1971 35
1972 34
1973 22
1974 28
1975 27
1976 24
1977 24
1978 59
1979 41
1980 40
1981 34
1982 57
1983 59
1984 65
1985 74
1986 62
1987 76
1988 69
1989 110
1990 85
1991 80
1992 83
1993 103
1994 114
1995 94
1996 95
1997 121
1998 102
1999 126
2000 122
2001 133
2002 138
2003 161
2004 141
2005 119
2006 135
2007 138
2008 157
2009 152
2010 173
2011 172
2012 216
2013 204
2014 227
2015 232
2016 198
2017 227
2018 226
2019 226
2020 276
2021 277
2022 35
Text availability
Article attribute
Article type
Publication date

Search Results

5,749 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With EGFR T790M-Mutated Non-Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor: West Japan Oncology Group 8715L Phase 2 Randomized Clinical Trial.
Akamatsu H, Toi Y, Hayashi H, Fujimoto D, Tachihara M, Furuya N, Otani S, Shimizu J, Katakami N, Azuma K, Miura N, Nishino K, Hara S, Teraoka S, Morita S, Nakagawa K, Yamamoto N. Akamatsu H, et al. Among authors: hayashi h. JAMA Oncol. 2021 Mar 1;7(3):386-394. doi: 10.1001/jamaoncol.2020.6758. JAMA Oncol. 2021. PMID: 33410885 Free PMC article.
Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Isomoto K, Haratani K, Hayashi H, Shimizu S, Tomida S, Niwa T, Yokoyama T, Fukuda Y, Chiba Y, Kato R, Tanizaki J, Tanaka K, Takeda M, Ogura T, Ishida T, Ito A, Nakagawa K. Isomoto K, et al. Among authors: hayashi h. Clin Cancer Res. 2020 Apr 15;26(8):2037-2046. doi: 10.1158/1078-0432.CCR-19-2027. Epub 2020 Jan 14. Clin Cancer Res. 2020. PMID: 31937613 Free article.
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration.
Drilon A, Clark JW, Weiss J, Ou SI, Camidge DR, Solomon BJ, Otterson GA, Villaruz LC, Riely GJ, Heist RS, Awad MM, Shapiro GI, Satouchi M, Hida T, Hayashi H, Murphy DA, Wang SC, Li S, Usari T, Wilner KD, Paik PK. Drilon A, et al. Among authors: hayashi h. Nat Med. 2020 Jan;26(1):47-51. doi: 10.1038/s41591-019-0716-8. Epub 2020 Jan 13. Nat Med. 2020. PMID: 31932802 Free PMC article.
Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.
Hayashi H, Fukutomi Y, Mitsui C, Kajiwara K, Watai K, Kamide Y, Nakamura Y, Hamada Y, Tomita Y, Sekiya K, Tsuburai T, Izuhara K, Wakahara K, Hashimoto N, Hasegawa Y, Taniguchi M. Hayashi H, et al. Am J Respir Crit Care Med. 2020 Jun 15;201(12):1488-1498. doi: 10.1164/rccm.201906-1215OC. Am J Respir Crit Care Med. 2020. PMID: 32142372 Free PMC article. Clinical Trial.
Exosome-Derived microRNA-22 Ameliorates Pulmonary Fibrosis by Regulating Fibroblast-to-Myofibroblast Differentiation in Vitro and in Vivo.
Kuse N, Kamio K, Azuma A, Matsuda K, Inomata M, Usuki J, Morinaga A, Tanaka T, Kashiwada T, Atsumi K, Hayashi H, Saito Y, Seike M, Gemma A. Kuse N, et al. Among authors: hayashi h. J Nippon Med Sch. 2020 Jul 13;87(3):118-128. doi: 10.1272/jnms.JNMS.2020_87-302. Epub 2019 Nov 28. J Nippon Med Sch. 2020. PMID: 31776321 Free article.
Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression.
Shiizaki K, Tsubouchi A, Miura Y, Seo K, Kuchimaru T, Hayashi H, Iwazu Y, Miura M, Battulga B, Ohno N, Hara T, Kunishige R, Masutani M, Negishi K, Kario K, Kotani K, Yamada T, Nagata D, Komuro I, Itoh H, Kurosu H, Murata M, Kuro-O M. Shiizaki K, et al. Among authors: hayashi h. J Clin Invest. 2021 Aug 16;131(16):e145693. doi: 10.1172/JCI145693. J Clin Invest. 2021. PMID: 34185705 Free PMC article.
A small moleculeĀ compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication.
Hattori SI, Higashi-Kuwata N, Hayashi H, Allu SR, Raghavaiah J, Bulut H, Das D, Anson BJ, Lendy EK, Takamatsu Y, Takamune N, Kishimoto N, Murayama K, Hasegawa K, Li M, Davis DA, Kodama EN, Yarchoan R, Wlodawer A, Misumi S, Mesecar AD, Ghosh AK, Mitsuya H. Hattori SI, et al. Among authors: hayashi h. Nat Commun. 2021 Jan 28;12(1):668. doi: 10.1038/s41467-021-20900-6. Nat Commun. 2021. PMID: 33510133 Free PMC article.
Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing Ī²1 Integrin, Enhancing Drug Resistance.
Uchihara T, Miyake K, Yonemura A, Komohara Y, Itoyama R, Koiwa M, Yasuda T, Arima K, Harada K, Eto K, Hayashi H, Iwatsuki M, Iwagami S, Baba Y, Yoshida N, Yashiro M, Masuda M, Ajani JA, Tan P, Baba H, Ishimoto T. Uchihara T, et al. Among authors: hayashi h. Cancer Res. 2020 Aug 15;80(16):3222-3235. doi: 10.1158/0008-5472.CAN-19-3803. Epub 2020 Jun 30. Cancer Res. 2020. PMID: 32605995 Free article.
Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?
Sumida Y, Yoneda M, Toyoda H, Yasuda S, Tada T, Hayashi H, Nishigaki Y, Suzuki Y, Naiki T, Morishita A, Tobita H, Sato S, Kawabe N, Fukunishi S, Ikegami T, Kessoku T, Ogawa Y, Honda Y, Nakahara T, Munekage K, Ochi T, Sawada K, Takahashi A, Arai T, Kogiso T, Kimoto S, Tomita K, Notsumata K, Nonaka M, Kawata K, Takami T, Kumada T, Tomita E, Okanoue T, Nakajima A, Japan Study Group Of Nafld Jsg-Nafld. Sumida Y, et al. Among authors: hayashi h. Int J Mol Sci. 2020 Jul 13;21(14):4939. doi: 10.3390/ijms21144939. Int J Mol Sci. 2020. PMID: 32668632 Free PMC article. Review.
5,749 results